Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel Free ACB Stock Alerts

Aurora Cannabis (ACB) Financials

Aurora Cannabis logo
$2.72 -0.02 (-0.73%)
Closing price 07/28/2026 04:00 PM Eastern
Extended Trading
$2.74 +0.02 (+0.74%)
As of 07:42 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Aurora Cannabis

Annual Income Statements for Aurora Cannabis

This table shows Aurora Cannabis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 50 -274 -2,451 -558 -1,510 -79 15 -86
Consolidated Net Income / (Loss)		 53 -229 -2,436 -561 -1,335 -51 1.11 -97
Net Income / (Loss) Continuing Operations		 32 -229 -2,398 -559 -1,510 -79 16 -86
Total Pre-Tax Income 		38 -250 -2,643 -564 -1,510 -79 16 -86
Total Operating Income		 -73 -241 -343 -228 -1,493 -79 -27 -86
Total Gross Profit		 33 108 -266 -17 -41 97 126 98
Total Revenue		 42 187 198 396 124 0.00 154 0.00
Total Cost of Revenue		 33 125 397 431 165 0.00 100 0.00
Total Operating Expenses		 106 351 328 211 1,452 79 80 86
Selling, General & Admin Expense		 61 203 188 113 88 67 64 76
Research & Development Expense		 1.28 11 19 9.23 8.07 2.64 4.95 2.88
Other Operating Expenses / (Income)		 - - - - 175 9.26 8.99 7.07
Total Other Income / (Expense), net		 132 -9.42 -2,115 -336 -17 0.00 42 0.00
Weighted Average Basic Shares Outstanding		 - 1.02B 115.23M 198.07M 297.77M 54.55M 56.23M 58.95M
Weighted Average Diluted Shares Outstanding		 - 1.02B 115.23M 198.07M 297.77M 54.55M 56.23M 58.95M
Weighted Average Basic & Diluted Shares Outstanding		 - 1.02B 115.23M 198.07M 297.77M 54.55M 56.23M 58.95M

Quarterly Income Statements for Aurora Cannabis

No quarterly income statements for Aurora Cannabis are available.

Annual Cash Flow Statements for Aurora Cannabis

This table details how cash moves in and out of Aurora Cannabis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -63 73 -7.76 209 13 -44 6.60 -24
Net Cash From Operating Activities		 62 -146 -252 -170 -86 -63 8.20 12
Net Cash From Continuing Operating Activities		 -62 -146 -234 -153 -94 -63 8.20 12
Net Income / (Loss) Continuing Operations		 53 -229 -2,398 -559 -1,335 0.00 0.00 0.00
Depreciation Expense		 6.09 35 55 49 47 24 8.55 9.59
Amortization Expense		 3.24 33 30 30 26 3.48 2.87 3.31
Non-Cash Adjustments To Reconcile Net Income		 -129 34 2,136 333 1,170 -89 -1.02 -0.52
Changes in Operating Assets and Liabilities, net		 4.90 -18 -57 -5.20 -1.70 -1.23 -2.19 0.04
Net Cash From Investing Activities		 -408 -238 -181 -22 -28 9.07 1.38 -37
Net Cash From Continuing Investing Activities		 -408 -238 -199 -38 -28 9.07 1.38 -37
Purchase of Investments		 - -39 -1.47 -5.38 - - 0.00 -37
Sale of Property, Plant & Equipment		 -104 0.00 0.92 16 15 9.07 1.38 0.79
Net Cash From Financing Activities		 407 455 429 421 115 10 -2.98 0.59
Net Cash From Continuing Financing Activities		 407 450 430 421 115 10 -2.98 0.59
Other Financing Activities, net		 -10 -25 35 -16 -25 1.57 -2.98 0.59

Quarterly Cash Flow Statements for Aurora Cannabis

No quarterly cash flow statements for Aurora Cannabis are available.

Annual Balance Sheets for Aurora Cannabis

This table presents Aurora Cannabis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets		 1,434 4,187 2,046 2,101 842 685 619 593 431
Total Current Assets		 167 503 307 537 579 355 315 333 285
Cash & Equivalents		 58 132 119 340 340 174 101 96 46
Restricted Cash		 10 35 0.00 16 40 49 32 33 34
Short-Term Investments		 0.00 109 14 3.03 1.03 0.00 3.54 0.00 37
Accounts Receivable		 11 79 40 45 37 31 34 30 32
Inventories, net		 36 123 118 124 156 78 106 131 111
Prepaid Expenses		 5.77 19 16 9.01 5.08 6.12 6.94 7.80 7.97
Other Current Assets		 45 - - - - 17 32 36 14
Plant, Property, & Equipment, net		 187 583 697 489 181 0.00 0.00 186 89
Total Noncurrent Assets		 1,080 3,101 1,042 1,075 82 91 87 74 57
Long-Term Investments		 95 66 44 48 20 5.36 - 0.00 8.68
Noncurrent Note & Lease Receivables		 - 0.00 2.68 12 3.44 4.80 4.68 3.66 2.63
Goodwill		 578 2,415 683 716 0.00 14 32 31 19
Intangible Assets		 152 524 303 296 55 44 30 31 23
Noncurrent Deferred & Refundable Income Taxes		 - - - - 0.00 11 11 2.93 1.76
Other Noncurrent Operating Assets		 0.00 5.27 9.08 2.85 2.45 12 8.88 5.37 2.59
Total Liabilities & Shareholders' Equity		 1,434 4,187 2,046 2,101 842 685 619 593 431
Total Liabilities		 254 846 483 457 328 299 175 170 64
Total Current Liabilities		 57 332 200 94 102 176 92 77 48
Short-Term Debt		 1.86 211 122 28 21 105 39 15 0.00
Accounts Payable		 36 116 70 47 54 53 43 51 36
Current Deferred & Payable Income Tax Liabilities		 1.26 - - 0.00 0.13 0.12 1.14 5.29 4.99
Other Current Liabilities		 16 3.20 5.96 15 23 17 7.73 4.92 5.81
Total Noncurrent Liabilities		 195 514 283 363 215 114 83 93 16
Long-Term Debt		 153 436 218 311 184 62 38 61 0.36
Capital Lease Obligations		 - - 62 53 29 32 32 26 13
Noncurrent Deferred & Payable Income Tax Liabilities		 42 69 2.90 0.00 2.22 12 12 1.32 0.00
Other Noncurrent Operating Liabilities		 0.00 9.12 0.03 0.08 0.10 7.12 1.71 3.85 2.65
Total Equity & Noncontrolling Interests		 1,181 3,340 1,563 1,643 515 386 445 423 367
Total Preferred & Common Equity		 1,177 3,337 1,581 1,643 514 363 413 394 367
Total Common Equity		 1,177 3,337 1,581 1,643 514 363 413 394 367
Common Stock		 1,115 3,558 4,258 5,181 5,248 5,058 5,149 4,862 5,022
Retained Earnings		 67 -218 -2,647 -3,485 -4,691 -4,652 -4,703 -4,429 -4,617
Accumulated Other Comprehensive Income / (Loss)		 -0.41 -109 -138 -167 -164 -157 -152 -150 -153
Other Equity Adjustments		 -4.02 106 107 114 122 114 120 111 115
Noncontrolling Interest		 3.47 3.36 -18 0.00 0.40 23 31 29 0.00

Quarterly Balance Sheets for Aurora Cannabis

No quarterly balance sheets for Aurora Cannabis are available.

Annual Metrics And Ratios for Aurora Cannabis

This table displays calculated financial ratios and metrics derived from Aurora Cannabis' official financial filings.

Metric 2018 2019 2020 2021 2022 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding		 0.00 1,017,438,744.00 115,228,811.00 198,068,923.00 297,772,238.00 - 56,234,231.00 58,947,593.00
DEI Adjusted Shares Outstanding		 0.00 8,478,656.00 11,522,881.00 19,806,892.00 29,777,224.00 - 56,234,231.00 58,947,593.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 -32.36 -212.70 -28.18 -50.71 - 0.27 -1.46
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 345.43% 5.80% 100.03% -68.71% 0.00% 0.00% -100.00%
EBITDA Growth		 0.00% -377.24% -1,180.37% 81.48% -227.12% 0.00% 137.92% -470.06%
EBIT Growth		 0.00% -538.56% -873.62% 78.90% -191.33% 0.00% 110.62% -1,123.99%
NOPAT Growth		 0.00% -176.44% -42.43% 33.47% -554.66% 0.00% 51.92% -126.28%
Net Income Growth		 0.00% -534.79% -964.35% 76.98% -138.10% 0.00% 102.16% -8,906.73%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 0.00% -335.71% -72.06% 32.56% 49.56% 0.00% 112.94% 51.44%
Free Cash Flow Firm Growth		 0.00% 0.00% 161.31% -100.29% 5,532.02% 0.00% 0.00% 137.38%
Invested Capital Growth		 0.00% 210.74% -50.99% -8.67% -79.85% 0.00% 99.39% -36.35%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - -
Gross Margin		 78.84% 58.01% -134.37% -4.40% -33.52% 0.00% 81.98% 0.00%
EBITDA Margin		 159.63% -99.36% -1,202.42% -111.34% -1,164.09% 0.00% 12.93% 0.00%
Operating Margin		 -173.51% -128.76% -173.34% -57.66% -1,206.40% 0.00% -17.40% 0.00%
EBIT Margin		 137.42% -135.30% -1,245.11% -131.34% -1,222.88% 0.00% 5.49% 0.00%
Profit (Net Income) Margin		 125.42% -122.42% -1,231.61% -141.71% -1,078.36% 0.00% 0.72% 0.00%
Tax Burden Percent		 139.30% 91.50% 92.17% 99.33% 88.39% 63.64% 7.09% 112.88%
Interest Burden Percent		 65.52% 98.89% 107.32% 108.63% 99.77% 100.00% 185.09% 100.00%
Effective Tax Rate		 16.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -5.19% -6.99% -8.83% -9.34% -106.61% 0.00% -8.95% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -1,551.67% -47.42% -837.16% -386.17% 785.09% 0.00% -29.47% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 9.65% -3.13% -90.53% -25.63% -25.16% 0.00% 9.21% 0.00%
Return on Equity (ROE)		 4.46% -10.12% -99.36% -34.97% -131.78% -12.33% 0.26% -24.67%
Cash Return on Invested Capital (CROIC)		 0.00% -109.61% 59.61% -0.28% 26.31% 0.00% -75.34% 25.84%
Operating Return on Assets (OROA)		 4.02% -9.00% -79.02% -25.06% -108.68% 0.00% 1.39% 0.00%
Return on Assets (ROA)		 3.67% -8.14% -78.16% -27.04% -95.83% 0.00% 0.18% 0.00%
Return on Common Equity (ROCE)		 4.44% -10.11% -99.65% -35.17% -130.28% -11.53% 0.24% -23.77%
Return on Equity Simple (ROE_SIMPLE)		 4.47% -6.86% -154.10% -34.11% -371.40% -12.38% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -61 -168 -240 -160 -1,045 -56 -27 -60
NOPAT Margin		 -145.23% -90.14% -121.34% -40.36% -844.48% 0.00% -17.40% 0.00%
Net Nonoperating Expense Percent (NNEP)		 1,546.47% 40.42% 828.33% 376.83% -891.71% 2.09% 20.52% -52.98%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - -5.08% -15.89%
Cost of Revenue to Revenue		 78.22% 66.92% 200.79% 108.94% 133.52% 0.00% 65.28% 0.00%
SG&A Expenses to Revenue		 145.69% 108.38% 95.10% 28.48% 71.06% 0.00% 41.37% 0.00%
R&D to Revenue		 3.04% 6.02% 9.69% 2.33% 6.52% 0.00% 3.22% 0.00%
Operating Expenses to Revenue		 252.36% 187.64% 165.93% 53.26% 1,172.88% 0.00% 52.12% 0.00%
Earnings before Interest and Taxes (EBIT)		 58 -253 -2,462 -520 -1,514 -80 8.43 -86
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 67 -186 -2,378 -440 -1,441 -53 20 -73
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.67 0.63 0.73 0.37 0.61 0.50
Price to Tangible Book Value (P/TBV)		 0.00 0.00 1.77 1.65 0.87 0.43 0.72 0.57
Price to Revenue (P/Rev)		 0.00 0.00 5.32 2.63 2.11 0.00 1.56 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 15.82 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.32% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.70 0.63 0.67 0.78 0.61 0.28
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 6.37 2.60 1.78 0.00 1.58 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 12.19 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 28.68 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 29.48 5.68
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.78 0.00 0.86 0.00 0.00 0.84
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.13 0.19 0.26 0.24 0.43 0.24 0.24 0.04
Long-Term Debt to Equity		 0.13 0.13 0.18 0.22 0.15 0.16 0.21 0.04
Financial Leverage		 -0.01 0.07 0.11 0.07 -0.03 -0.55 -0.31 -0.18
Leverage Ratio		 1.21 1.24 1.27 1.29 1.38 1.57 1.40 1.30
Compound Leverage Factor		 0.80 1.23 1.36 1.41 1.37 1.57 2.59 1.30
Debt to Total Capital		 11.57% 16.24% 20.44% 19.25% 30.05% 19.53% 19.49% 3.51%
Short-Term Debt to Total Capital		 0.14% 5.30% 6.19% 1.39% 19.23% 7.00% 2.85% 0.00%
Long-Term Debt to Total Capital		 11.43% 10.93% 14.26% 17.86% 10.82% 12.53% 16.64% 3.51%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.26% 0.08% -0.91% 0.00% 4.20% 5.63% 5.48% 0.00%
Common Equity to Total Capital		 88.17% 83.68% 80.47% 80.75% 65.75% 74.84% 75.03% 96.49%
Debt to EBITDA		 2.31 -3.49 -0.17 -0.89 -0.11 -2.03 5.16 -0.18
Net Debt to EBITDA		 -0.14 -1.65 -0.09 0.03 0.04 0.53 -1.33 1.54
Long-Term Debt to EBITDA		 2.28 -2.35 -0.12 -0.83 -0.04 -1.30 4.41 -0.18
Debt to NOPAT		 -2.54 -3.84 -1.67 -2.45 -0.16 -1.92 -3.84 -0.22
Net Debt to NOPAT		 0.15 -1.82 -0.93 0.09 0.06 0.50 0.99 1.88
Long-Term Debt to NOPAT		 -2.50 -2.59 -1.17 -2.28 -0.06 -1.23 -3.28 -0.22
Altman Z-Score		 0.00 0.00 -4.32 -1.33 -15.80 -10.11 -8.79 -13.28
Noncontrolling Interest Sharing Ratio		 0.29% 0.15% -0.30% -0.56% 1.13% 6.51% 6.90% 3.65%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 2.92 1.51 1.53 5.72 1.98 3.42 4.31 5.94
Quick Ratio		 1.22 0.96 0.86 4.14 1.14 1.31 1.63 2.41
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -2,641 1,619 -4.75 258 0.00 -225 84
Operating Cash Flow to CapEx		 59.63% -46.41% -98.44% -622.25% -877.57% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.03 0.07 0.06 0.19 0.09 0.00 0.25 0.00
Accounts Receivable Turnover		 3.66 4.14 3.33 9.29 3.26 0.00 4.87 0.00
Inventory Turnover		 0.91 1.57 3.29 3.56 1.63 0.00 0.85 0.00
Fixed Asset Turnover		 0.22 0.49 0.31 0.67 0.34 0.00 0.00 0.00
Accounts Payable Turnover		 0.91 1.64 4.25 7.36 3.22 0.00 2.12 0.00
Days Sales Outstanding (DSO)		 99.83 88.13 109.46 39.31 111.93 0.00 74.99 0.00
Days Inventory Outstanding (DIO)		 402.73 232.63 110.84 102.42 223.49 0.00 431.19 0.00
Days Payable Outstanding (DPO)		 401.20 222.43 85.82 49.58 113.52 0.00 172.00 0.00
Cash Conversion Cycle (CCC)		 101.36 98.33 134.48 92.14 221.91 0.00 334.17 0.00
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 1,173 3,646 1,787 1,632 329 199 397 253
Invested Capital Turnover		 0.04 0.08 0.07 0.23 0.13 0.00 0.51 0.00
Increase / (Decrease) in Invested Capital		 0.00 2,473 -1,859 -155 -1,303 0.00 198 -144
Enterprise Value (EV)		 0.00 0.00 1,259 1,027 221 155 242 71
Market Capitalization		 0.00 0.00 1,053 1,042 261 152 239 184
Book Value per Share		 $0.00 $3.28 $1.55 $14.26 $1.81 $1.20 $7.23 $6.52
Tangible Book Value per Share		 $0.00 $0.39 $0.58 $5.48 $1.52 $1.02 $6.10 $5.78
Total Capital		 1,335 3,988 1,964 2,035 547 552 526 380
Total Debt		 155 647 402 392 164 108 102 13
Total Long-Term Debt		 153 436 280 363 59 69 87 13
Net Debt		 -9.06 306 224 -15 -64 -28 -26 -113
Capital Expenditures (CapEx)		 104 315 256 27 9.76 -9.07 -1.38 -0.79
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 43 107 95 113 58 126 142 119
Debt-free Net Working Capital (DFNWC)		 112 382 228 472 281 262 271 237
Net Working Capital (NWC)		 110 171 107 443 176 223 256 237
Net Nonoperating Expense (NNE)		 -114 60 2,196 401 289 -5.12 -28 37
Net Nonoperating Obligations (NNO)		 -7.34 306 224 -11 -54 -245 -26 -114
Total Depreciation and Amortization (D&A)		 9.32 67 84 79 73 27 11 13
Debt-free, Cash-free Net Working Capital to Revenue		 102.91% 57.01% 48.12% 28.55% 47.14% 0.00% 92.26% 0.00%
Debt-free Net Working Capital to Revenue		 266.29% 204.46% 115.50% 119.19% 226.85% 0.00% 176.22% 0.00%
Net Working Capital to Revenue		 261.85% 91.32% 54.06% 112.03% 141.94% 0.00% 166.48% 0.00%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($339.40) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 8.48M 11.52M 19.81M 29.78M 54.55M 56.23M 58.95M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($339.40) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 8.48M 11.52M 19.81M 29.78M 54.55M 56.23M 58.95M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($339.40) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 8.48M 11.52M 19.81M 29.78M 54.55M 56.23M 58.95M
Normalized Net Operating Profit after Tax (NOPAT)		 -51 -159 -237 -156 -245 -56 -18 -60
Normalized NOPAT Margin		 -121.48% -85.23% -119.65% -39.54% -197.87% 0.00% -11.96% 0.00%
Pre Tax Income Margin		 90.04% -133.80% -1,336.28% -142.67% -1,220.05% 0.00% 10.16% 0.00%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -311.45% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Aurora Cannabis

No quarterly metrics and ratios for Aurora Cannabis are available.


Financials Breakdown Chart

Aurora Cannabis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Aurora Cannabis' fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

Aurora Cannabis' net income appears to be on a downward trend, with a most recent value of -$97.44 million in 2026, falling from $52.63 million in 2018. The previous period was $1.11 million in 2025. Check out Aurora Cannabis' forecast to explore projected trends and price targets.

Aurora Cannabis' total operating income in 2026 was -$86.33 million, based on the following breakdown:
  • Total Gross Profit: $97.94 million
  • Total Operating Expenses: $86.33 million

Over the last 7 years, Aurora Cannabis' total revenue changed from $41.97 million in 2018 to $0.00 in 2026, a change of -100.0%.

Aurora Cannabis' total liabilities were at $63.97 million at the end of 2026, a 62.3% decrease from 2025, and a 74.8% decrease since 2018.

In the past 8 years, Aurora Cannabis' cash and equivalents has ranged from $46.36 million in 2026 to $340.15 million in 2022, and is currently $46.36 million as of their latest financial filing in 2026.

Over the last 7 years, Aurora Cannabis' book value per share changed from 0.00 in 2018 to 6.52 in 2026, a change of 652.3%.


Related Companies

Financial statements for NASDAQ:ACB last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel